159 related articles for article (PubMed ID: 1664946)
1. Adenylyl cyclase stimulation by VIP in rat seminal vesicle membranes.
Rodriguez-Pena MS; Guijarro LG; Prieto JC
Peptides; 1991; 12(4):821-4. PubMed ID: 1664946
[TBL] [Abstract][Full Text] [Related]
2. Characterization of adenylyl cyclase stimulated by VIP in rat and mouse peritoneal macrophage membranes.
Pozo D; Segura JJ; Carrero I; Guijarro LG; Prieto JC; Calvo JR
Biochim Biophys Acta; 1996 Jul; 1312(3):249-54. PubMed ID: 8703995
[TBL] [Abstract][Full Text] [Related]
3. Analysis of vasoactive intestinal peptide receptors and the G protein regulation of adenylyl cyclase in seminal vesicle membranes from streptozotocin-diabetic rats.
Rodriguez-Pena MS; Guijarro LG; Juarranz MG; Rodriguez-Henche N; Bajo AM; Aguado F; Prieto JC
Cell Signal; 1994 Feb; 6(2):147-56. PubMed ID: 8086277
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
Rodríguez-Pena MS; Guijarro LG; Prieto JC
Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides.
Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC
Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008
[TBL] [Abstract][Full Text] [Related]
6. Adenylate cyclase stimulation by VIP in rat and human parotid membranes.
van Bogaert P; Soukias Y; Dehaye JP; Lambert M; Poloczek P; Winand J; Mayer R; Christophe J
Regul Pept; 1987 Jun; 17(6):339-48. PubMed ID: 3602475
[TBL] [Abstract][Full Text] [Related]
7. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.
Guijarro LG; Rodriguez-Pena MS; Prieto JC
Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
9. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
Prieto JC; Guerrero JM; de Miguel C; Goberna R
Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
[TBL] [Abstract][Full Text] [Related]
10. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J
Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606
[TBL] [Abstract][Full Text] [Related]
11. The effect of vasoactive intestinal polypeptide (VIP) on forskolin stimulated adenylate cyclase in the caudate-putamen of the rat.
Moser A; Drescher S
Exp Brain Res; 1990; 79(2):383-7. PubMed ID: 2323384
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic ethanol ingestion on the vasoactive intestinal peptide receptor-effector system from rat seminal vesicle membranes.
Juarranz MG; Marinero MJ; Bodega G; Prieto JC; Guijarro LG
Alcohol Clin Exp Res; 1999 Feb; 23(2):318-23. PubMed ID: 10069562
[TBL] [Abstract][Full Text] [Related]
13. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
14. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
Charlton BG; Neal DE; Simmons NL
J Physiol; 1990 Apr; 423():475-84. PubMed ID: 2167366
[TBL] [Abstract][Full Text] [Related]
16. G-protein regulation of adenylate cyclase activity in rat prostatic membranes after chronic ethanol ingestion.
Juarranz MG; Guijarro LG; Bodega G; Prieto JC
Prostate; 1998 Sep; 36(4):226-34. PubMed ID: 9719022
[TBL] [Abstract][Full Text] [Related]
17. Characterization of vasoactive intestinal peptide receptors in human liver.
Rodríguez-Henche N; Rodríguez-Pena MS; Guijarro LG; Prieto JC
Biochim Biophys Acta; 1994 Mar; 1221(2):193-8. PubMed ID: 8148398
[TBL] [Abstract][Full Text] [Related]
18. Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors.
Takahashi K; Nakanishi S; Imamura S
J Invest Dermatol; 1993 Nov; 101(5):646-51. PubMed ID: 8228323
[TBL] [Abstract][Full Text] [Related]
19. Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes.
Robberecht P; Waelbroeck M; de Neef P; Camus JC; Vandermeers A; Vandermeers-Piret MC; Christophe J
FEBS Lett; 1984 Jun; 172(1):55-8. PubMed ID: 6329822
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of [125I]VIP binding sites and effects of VIP on cAMP-formation in rat insulinoma (RINm5F and RIN14B) cells.
Andersson M; Sillard R; Rökaeus A
Regul Pept; 1992 Jul; 40(1):41-9. PubMed ID: 1332138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
